Cutaneous melanoma: Clinical features of 32 Hong Kong Chinese patients

Hong Kong Journal of Dermatology and Venereology

Volumn 13, Issue 3, 2005, Pages 130-140

  Hui, S K ^a,e   Lau, K H ^a   Leung, C Y ^a   Tang, W Y M ^a   Yau, K C ^b   Trendell Smith, N J ^c   Wong, T W ^d   Chong, L Y ^a   Lo, K K ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b Department of Health   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e Yau Ma Tei Specialist Clinic   (Hong Kong)

Author keywords

Chinese; Clinical features; Cutaneous melanoma

Indexed keywords

ADULT; AGED; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FATALITY; FEMALE; FOOT; HEALTH CARE PERSONNEL; HISTOLOGY; HUMAN; MALE; MELANOCYTIC NEVUS; MELANOMA; PREVALENCE; PROGNOSIS; PYOGENIC GRANULOMA; RETROSPECTIVE STUDY; SEBORRHEIC KERATOSIS; SYMPTOMATOLOGY; TUMOR VOLUME;

EID: 24744459439     PISSN: 18147453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. World Health Organization. GLOBOCAN: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancerbase No.5 Version 1.0. Lyon: IARC, 2001.
2. Desmond RA, Soong SJ. Epidemiology of malignant melanoma. Surg Clin North Am 2003;83:1-29.
3. Chen YJ, Wu CY, Chen JT, Shen JL, Chen CC, Wang HC. Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol 1999;41:945-9.
4. Luk NM, Ho LC, Choi CL, Wong KH, Yu KH, Yeung WK. Clinicopathological features and prognostic factors of cutaneous melanoma among Hong Kong Chinese. Clin Exp Dermatol 2004;29:600-4.
5. Collins RJ. Melanoma in the Chinese of Hong Kong. Emphasis on volar and subungual sites. Cancer 1984;54:1482-8.
6. Sun DJ, Gao TW, Li CY, Liu RQ, Li Q, Liu YS, et al. Review of Cutaneous malignant melanoma from two general hospitals in Western China, 1981-2000. Chin J Dermatol 2004;37:97-9.
7. Tan E, Chua SH, Lim JT, Goh CL. Malignant melanoma seen in a tertiary dermatological centre, Singapore. Ann Acad Med Singapore 2001;30:414-8.
8. Xia JX, Pang CC, Li YL. Clinical and prognosis analysis of 72 cases with malignant melanoma in Hukuoka, Japan. J N Bethune Univ Med Sci 2001;27:422-4.
9. Stolz W, Schmoeckel C, Landthaler M, Braun-Falco O. Association of early malignant melanoma with nevocytic nevi. Cancer 1989;63:550-5.
10. Langley RGB, Barnhill RL, Mihm MC Jr, Fitzpatrick TB, Sober AJ. Neoplasms: Cutaneous Melanoma. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Dermatology in General Medicine. Vol 2. 6th ed. New York, NY: McGraw-Hill Book Co; 2003: 917-48.
11. Nestle FO, Kerl H. Melanoma. In: Bolognia JL, Jorizzo JL, Rapini RP, et al, eds. Dermatology. Vol.2. 1st ed. Philadelphia, USA: Elsevier Ltd; 2003:1789-815.
12. MacKie RM. Melanocytic nevi and malignant melanoma. In: Champion RH, Burton JL, Burns DA, Breaathnach SM, eds. Textbook of Dermatology. Vol 2. 6th ed. Oxford, England: Blackwill Science Ltd; 1998:1717-52.
13. Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA. Who discovers melanoma? Patterns from a population-based survey. J Am Acad Dermatol 1992;26:914-9.
14. McCarthy WH, Milton GW. Primary cutaneous melanoma: clincal diagnosis. In: Thompson JF, Morton DL, Kroon BBR. Textbook of Melanoma. 1st ed. London, UK: Martin Dunitz; 2004:214-24.
15. Shaw HM, McCarthy WH. Small-diameter malignant melanoma: a common diagnosis in New South Wales, Australia. J Am Acad Dermatol 1992;27(5 Pt 1): 679-82.
16. Barnhill RL, Fine JA, Roush GC, Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 1996;78:427-32.
17. Weyers W, Euler M, Diaz-Cascajo C, Schill WB, Bonczkowitz M. Classification of cutaneous malignant melanoma: a reassessment of histopathologic criteria for the distinction of different types. Cancer 1999;86:288-99.
18. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-34.
19. Ackerman AB, David KM. A unifying concept of malignant melanoma: biologic aspects. Hum Pathol 1986;17:438-40.
20. Barnhill RL. Malignant melanoma. In: Barnhill RL, Piepkorn M, Busam KJ. Pathology of melanocytic nevi and malignant melanoma. 2nd ed. New York. USA: Springer-Verlag New York, Inc.; 2004:238-356.
21. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000;89:1269-78.
22. Zettersten E, Shaikh L, Ramirez R, Kashani-Sabet M. Prognostic factors in primary cutaneous melanoma. Surg Clin North Am 2003;83:61-75.
23. Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H. Cutaneous melanomas associated with nevi. Arch Dermatol 2003;139:1620-4
24. Liu V, Mihm MC. Pathology of malignant melanoma. Surg Clin North Am 2003;83:31-60, v.
25. Sober AJ, Chuang TY, Duvic M, Farmer ER, Grichnik JM, Halpern AC, et al. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001;45:579-86.
26. Hong Kong Cancer Registry, Hospital Authority, Hong Kong Special Administrative Region, PRC. Avaiable from: http://www.ha.org.hk/cancereg.